Inventor · disambiguated record
Edith M. Hessel
Also filed as: HESSEL EDITH · HESSEL EDITH M
5 granted patents·4 pending applications·32 citations·filing 2007–2019
77Inventor score
Files withGLAXOSMITHKLINE IP DEV LTD3HESSEL EDITH M2DYNAVAX TECH CORP1FIVE PRIME THERAPEUTICS INC1SCHWEIZERISCHES FORSCHUNGSINSTITUT FUER HOCHGEBRIGSKLIMA UND MEDIZIN IN DAVOS1
Top patents by PatentIndex Score
9 records- 0187US10537597B2Use of Akkermansia muciniphila for treating inflammatory conditionsSCHWEIZERISCHES FORSCHUNGSINSTITUT FUR HOCHGEBRIGSKLIMA UND MEDIZIN IN DAVOS·Filed 2016·Granted Jan 21, 2020·11 cites·15 claims
- 0283US8815817B2Long term disease modification using immunostimulatory oligonucleotidesHESSEL EDITH M·Filed 2009·Granted Aug 26, 2014·9 cites·22 claims
- 0382US8252757B2Long term disease modification using immunostimulatory oligonucleotidesHESSEL EDITH M·Filed 2007·Granted Aug 28, 2012·9 cites·28 claims
- 0481US10960032B2Use of Akkermansia muciniphila for treating inflammatory conditionsSCHWEIZERISCHES FORSCHUNGSINSTITUT FUER HOCHGEBRIGSKLIMA UND MEDIZIN IN DAVOS·Filed 2019·Granted Mar 30, 2021·3 cites·14 claims
- 0556US9333254B2Long term disease modification using immunostimulatory oligonucleotidesDYNAVAX TECH CORP·Filed 2014·Granted May 10, 2016·0 cites·18 claims
- 0644US2016256466A1Pi3k inhibitor for treatment of respiratory diseaseGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Application pending·0 cites
- 0744US2016263109A1P13k inhibitor for treatment of respiratory diseaseGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Application pending·0 cites
- 0837US2019135911A1Treating respiratory diseases by targeting interleukin 4 induced 1 (il4i1)FIVE PRIME THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 0929US2017290844A1Methods of TreatmentGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Edith M. Hessel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →